Introduction 84
Endometriosis is an estrogen-dependent, chronic gynecological disorder associated with 85 pelvic pain and infertility, with a prevalence of 6-10% in the general population 6, 7, 13 . 86
Affected women experience dysmenorrhea, deep dyspareunia, dyschezia and dysuria 13, 37 87 associated with low quality of life 8 . The disorder is under-diagnosed or there is a delay in 88 diagnosis in many cases leading to chronic pelvic pain (CPP) 7, 28 . Diagnosis is made by 89 laparoscopy or laparotomy, where endometrial lesions are found in extra-uterine locations, 90 mainly the peritoneum and ovaries 6, 7, 13 . As endometriosis is not curable, its treatments 91 and therapies are targeted at infertility and symptom relief 7, 11 . Endometriosis is also 92 associated with other co-morbid conditions such as fibromyalgia and chronic fatigue 93 syndrome 11, 28 . Moreover, it has a significant adverse impact on work productivity, social 94 activity, family responsibilities, and daily life, resulting in a substantial economic burden on 95 society 11, 30 .
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It is well accepted that endometriosis is associated with dysmenorrhea, but it 97 is not known why some women undergo transition to a state of chronic pain, while others 98 do not 1 . Depending on the study population, 30-70% of women with CPP have 99 laparoscopic evidence of endometriosis 21, 34 . The pain symptoms, however, are poorly 100 correlated to the severity of endometriosis, and the pathophysiology of endometriosis-101 associated pain remains somewhat elusive 9, 14, 23, 25, 36, 37 . Pain mechanisms in 102 endometriosis are thought to be multifactorial; pain may be nociceptive, neuropathic or a 103 combination of these, and emotional, cognitive and behavioral components are also 104 Endometriosis is anticipated to subside in menopause, as it is an estrogen-110 dependent disorder. However, in cases of peripheral and central sensitization, pain 111 symptoms and hyperalgesia may persist beyond fertile age. As yet, no population-based 112 data exist on pain symptoms among women with a history of endometriosis at late 113 reproductive age. Thus, the aim of this study was to determine in a population-based 114 cohort study setting whether women with a self-reported history of endometriosis 115 experience altered pressure-pain sensitivity and adverse pain symptoms at age 46. 116
117

Materials and Methods 118
Study Population 119
The study population originated from the Northern Finland Birth Cohort 1966 (NFBC1966, 120 http://www.oulu.fi/nfbc) which is a unique, large, prospective, longitudinal dataset 121 comprising all expected births in 1966 in the Northern Finland area (live-born children 122 n=12058, females n=5889). Originally the cohort was established to investigate the life-123 courses of various health-related conditions. Enrollment in this database began at the 24 th 124 gestational week, and, after birth, data-collection points were established at ages 1, 14, 31 125 and 46 years, this study utilizing the latest data-collection point, thus being a secondary, 126 cross-sectional analysis of a prospective study cohort. 127
At 46 years of age, all participants who were alive and whose postal address 128 in Finland was known received a questionnaire (5123 women). This was the first 129 questionnaire in this longitudinal cohort study including questions on history of 130 endometriosis and pain symptoms. The response rate was 72%. Furthermore, all women 131 were also invited to undergo clinical examination including pressure-pain testing, and 2774 132 (55%) participated. All participants gave informed consent. The study followed the 133
principles of the Declaration of Helsinki and the Ethics Committee of the Northern 134
Ostrobothnia Hospital District approved the research. A flow chart of the study is shown in 135 Figure 1 . 136
Diagnosis of Endometriosis 137
The final analysis concerned all women self-reporting endometriosis, and those stating "no 138 endometriosis" were considered as controls. Self-reported diagnosis was derived from the 139 postal questionnaire item: "Have you ever been diagnosed with endometriosis by a 140 physician?" resulting in an endometriosis population of 284 women (8% among women 141 who answered the endometriosis question). There were 3390 women (92%) reporting no 142 endometriosis and were considered as controls ( Figure 1A) . 143
Verification of diagnosis 144
Self-reported diagnosis of endometriosis has only recently been described in the literature 145
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; hence the validity of the diagnosis was verified for the present study through the patient 146 records available at the original study site at Oulu University Hospital (Supplemental 147 Figure) . Thirty-seven women (13%) did not give permission to enter their patient records. 148
Of the 284 women with endometriosis we found patient records for 92 (32.4%). According 149 to the patient records available, 71/92 women (77.2 %) were diagnosed as having 150 endometriosis, of which 90.1% were established in laparoscopy/laparotomy. Fifteen 151 women did not have a diagnosis of endometriosis and six were classified as unclear 152 cases. It is possible that the diagnosis was established later in another hospital after 153 moving from the area (groups "no endometriosis" and "unclear cases"). We also estimated 154 the specificity of diagnoses from the national hospital discharge register including 155 diagnosis established during hospital polyclinic visits or during hospitalization. In the 156 endometriosis group 52% of the women also had a diagnosis in the national hospitaldischarge register, compared with 1.5% among the women reporting not having 158 endometriosis (Table 1) . Thus, we concluded that a self-reported history of endometriosis 159 is sufficiently a valid tool to identify endometriosis cases in this cohort. 160
Pressure-Pain Threshold (PPT) and Maximal Pain Tolerance (MaxPTo) 161
Pain measurements were carried out in 2470 controls and 234 women with endometriosis. 162
A few of the four measurement-site readings were missing as a result of technical 163 difficulties. Pressure-pain threshold and maxPTo readings were acquired using an 164 algometer (Somedic AB, Hörby, Sweden) with a 10-mm contact head, which was applied 165 perpendicularly to the skin. Briefly, the pressure was increased from 0 kPa at a constant 166 rate of 50 kPa/s. Instructions to participants were, "A pressure will be applied at a gradual 167 rate. Allow the pressure to increase until it reaches a point where it feels uncomfortable 168 and then press the button down. As we continue increasing the pressure, release the 169 button when you cannot tolerate the pressure any more". The former pressure value was 170 recorded as the PPT and the latter as MaxPTo. Pressure was terminated at the latest 171 when the safety maximum of 1200 kPa was reached. The PPT and MaxPTo 172 measurements were taken at four anatomical sites in the following order: 1) shoulder; the 173 mid-point of the upper trapezius muscle (subject in a prone position), 2) the mid-point of 174 the tibialis anterior muscle (supine position), 3) the dorsal aspect of the wrist joint line 175 (supine position), and 4) the L5/S1 interspinous space (prone position). The test sites were 176 identified and participants were positioned in a standardized manner. Each site was tested 177 twice. Of the peripheral sites, primarily the right side was used. The exact anatomical point 178 of pressure was shifted slightly between the tests in order to prevent sensitization of 179 nociceptors at the contact site. The highest value of the two measurements was used in 180 the analysis to avoid overestimating pain threshold or tolerance. In addition, mean PPT 181
and MaxPTo values at the four measured locations were calculated and used in the 182
analyses. 183
Questionnaires on pain sites, pain intensity and pain troublesomeness 184
The numbers of musculoskeletal pain sites were assessed as follows: 0, 1, 2, 3, 4 or 5-8 185 sites. The pain sites were derived from the questionnaire, in which the prevalence of 186 musculoskeletal pain during the previous 12-month period was investigated as follows: sites, were assessed by using a Numerical Rating Scale (NRS) off 0 (no pain / no 195 disability) to 10 (extremely severe or disabling pain). 196
Confounders 197
Infertility 198
Infertility was inquired about at age 46: "Have you ever suffered from infertility (yes/no)?" 199
Parity 200
Parity was inquired about at age 46: "How many deliveries you have experienced?" We 201 divided the women according to parity into three groups: no delivery, one delivery or more 202 than one delivery. 203
204
Contraceptive use 206
Current or past hormonal contraception use was inquired about at age 46 "Have you ever 207 used any hormonal contraception (yes/no)?" and "Are you currently using hormonal 208 contraception (yes/no)?" 209
BMI 210
Height and weight were both self-reported and measured at 46 years. In the clinical 211 examinations, participants' weight (kg) was measured with a digital scale, which was 212 calibrated regularly. Height (cm) was measured twice by using a standard calibrated 213 stadiometer. BMI (kg/m 2 ) was calculated by using measured height (average of two 214 measurements) and weight. Self-reported values were used if measured data was not 215
available. There was no statistically significant difference between the self-reported and 216
clinically measured BMI values. 217
Smoking 218
Smoking history and present smoking status were inquired about by way of two questions 219 at the age of 46 years: 1) "Have you ever smoked (yes/no)?" and 2) "Are you currently 220 smoking (yes/no)?" According to the answers we identified current and life-long 221
nonsmokers. 222
Alcohol use 223
The subjects were also asked if they used alcohol, and if so, what kinds, how often and 224 how much? Daily alcohol consumption was calculated according to the answers and 225 classified three ways: 1) never, 2) light 3) moderate or heavy use (women >20g/day). 226
Education 227
Education was classified into three groups by the number of years of education: 9 years, 228 9-12 years and more than 12 years. 229
Anxiety and Depressive symptoms 231
Anxiety and depressive symptoms were assessed via the 25-item Hopkins Symptom 232
Checklist (HSCL-25) at 46 years of age 22, 35 . HSCL-25 part I includes 10 items concerning 233 anxiety symptoms and part II, 15 items concerning depression. The scale varies between 234 1 and 4: 1 = not troublesome to 4 = extremely troublesome. The commonly used cut-off 235 point of 1.55 was used to pinpoint anxiety and depression symptoms 35 . 236
Statistical analyses 237
A Tobit regression model 33 was used to evaluate independent associations between 238 endometriosis and PPT/MaxPTo. The motivation behind this was the large amount of 239 censoring seen at the maximum limit of 1200 kPa. The interpretation of regression 240 coefficients depends on the probability of not being censored. The interpretation is a 241 combination of 1) the change in outcome, given that it is not censored, weighted by the 242 probability of not being censored; and 2) the change in the probability of not being 
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The prevalence of self-reported endometriosis was 8% and verification of the diagnosis 252 was carried out by examining the hospital records (Supplemental Figure) . Table 1 shows 253 the characteristics of the study women and the controls. Of note is the fact that in the self-254 reported endometriosis group there was a relatively high percentage of women also havinga diagnosis of endometriosis according to the hospital discharge register. The women with 256 self-reported endometriosis were more often nulliparous and suffering from infertility, 257 compared with controls. Use of hormonal contraceptives at any time was more frequent in 258 women with endometriosis. No statistically significant differences were observed between 259 the groups in terms of BMI, smoking, alcohol use or education level (Table 1) . 260
The distribution of pain perception in women according to different 261 conditions/confounders at age 46 is shown in Figure 2 . Self-reported endometriosis was 262 associated with statistically significant decreases in both pressure-pain threshold (p<0.05, 263 were depression, anxiety and smoking. Interestingly, BMI and contraceptive use at any 266 time seemed to increase the pain thresholds (Fig 2) . 267
In Tobit regression analysis, PPT measurement showed that the women with 268 endometriosis had on average a 34.0 kPa lower (-5.3% [-1.1,-9.5]) pain threshold 269 compared with controls (p<0.05). As for the measurement site, PPT measured at the wrist 270 was significantly lower in women reporting endometriosis (-37.5 kPa, p<0.05, Table 2 among women with endometriosis (p<0.001, Table 2 ) the change being significant at all 278 measurement sites, even after adjusting for BMI, anxiety and depressive symptoms, 279 smoking and contraceptive use (mean -51.2 kPa, p<0.001), wrist (-58.2kPa), shoulder (53.4 kPa), lower back (-58.0 kPa) and leg (-46.8 kPa).The most significant contributors 281 besides endometriosis that lowered maximum pain tolerance were anxiety, depression and 282 current smoking status (-29.7kPa, -28.5kPa, -34.2kPa, respectively) (p<0.05, Figure 2) . 283
The women were also screened for number of musculoskeletal pain sites (0, 284 1, 2, 3, 4, 5-8 sites), pain troublesomeness and pain intensity (Fig. 3) . Among women with 285 endometriosis there were significantly fewer reporting no pain sites (9.6% vs. 17.9%, 286 p<0.001, Fig. 3) . Overall, the women with endometriosis also reported more pain sites 287 compared with controls (1 site 17.4% vs. 16.2%, 2 sites 17.0% vs 18.5%, 3 sites 15.5% vs. . In the present study, regression analysis 308 suggested that endometriosis is associated independently with lower pain threshold and 309 tolerance, whereas the strongest factors further decreasing the pain threshold and the 310 maximal pain response were anxiety, depression and current smoking status. Given all 311 this, it is worth noting that depression has been previously shown to be associated with 312 
endometriosis. 358
There are several strengths but also some limitations in the present work. 359
This is the first population-based study carried out to investigate pain perception/sensitivity 360 related to a history of endometriosis in women of late reproductive age. Women with 361 endometriosis were identified from a unique, large population-based data set of 362 homogeneous ethnicity and age and with the possibility to adjust for several confounding 363 factors. The data included objective pain measurements as well as subjective 364 questionnaire data. Moreover, the data collection did not specifically target endometriosis 365 patients or patients only treated in hospitals. Hence, the questionnaires and clinical 366 measurements were carried out in the whole cohort, with minimal self-aware bias. The 367 study also has limitations, which include self-reported endometriosis diagnosis and lack of 368 data on clinical symptoms of endometriosis; thus it is possible that the control group also 369 included women with endometriosis, albeit with milder pain symptoms/sensitivity. 370
However, the control group in the present data set was fairly large and such cases would 371 have been diluted among the controls. Moreover, studies on endometriosis commonly 372 concern only laparoscopically verified cases, and thus women with endometriosis with 373 fewer pain symptoms are most likely underrepresented in these studies. The self-reported 374 diagnoses of endometriosis may also be considered as a limitation, although, the 375 diagnosis was validated from the patient records available and from the national hospital 376 discharge register. In a recent study by Saha et al, similar results were presented when 377 self-reported endometriosis diagnoses were verified from patient records 26 . This was 378 further supported by a recent study validating self-reported endometriosis diagnosis in a 379
Swedish national twin registry 27 . The authors concluded that self-reported diagnosis 380 seems to be moderately accurate, and when additional information is also available the 381 accuracy is even better. It must be noted, however, that even though laparoscopy is the 382 gold standard in endometriosis diagnosis, in some milder cases the operation is not 383 justified and thus the diagnosis remains clinical. Although our measurements showed 384 statistically significant 5% decreases in pain threshold and maximal pain tolerance in 385 women with endometriosis, the clinical significance remains uncertain, although these 386 women also self-reported more pain symptoms. Furthermore, the associations between 387 endometriosis-related pain symptoms and other comorbid pain syndromes, menopause or 388 estradiol levels were not investigated due to lack of available data, thus these aspects 389 remain to be evaluated in future studies. 390
To conclude, this is the first population-based study showing a decreased pain 391 threshold and a decreased maximal pain response among women of late fertile age with a 392 history of endometriosis. The fact that the women also reported a higher number of pain 393 sites, with a greater prevalence of troublesome and intense pain at age 46 underlines the 394 fact that endometriosis may have a long-term footprint as regards pain perception in these 395 women. Given all this, women with endometriosis symptoms should be screened and 396 diagnosed as early as possible by a multidisciplinary team in order to ensure minimal 397 comorbidity, adequate pain relief and psychological support. Further studies are warranted 398 to address the diagnostic difficulties and different endometriosis phenotypes and also to 399 elucidate the pain mechanisms and best treatment options for these women. 
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